First published · Last updated
Circulating PD-L1–positive tumor cells in hepatocellular carcinoma are associated with survival but not with response to immunotherapy
A journal article reports that circulating PD-L1–positive tumor cells in hepatocellular carcinoma are associated with survival but not with response to immunotherapy. The source is a journal article published by Georg Thieme Verlag KG on 2026-08-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
An association with survival pertains directly to patient outcome measures.

